【ChiCTR1900024372】Communication and management of incidental pathology in 1,214 consecutive appendicectomies: a cohort study
ChiCTR1900024372
结束
/
/
/
2019-07-07
/
/
Important incidental pathology on appendicectomy speciment.
Communication and management of incidental pathology in 1,214 consecutive appendicectomies: a cohort study
Communication and management of incidental pathology in 1,214 consecutive appendicectomies: a cohort study
3011
Important incidental pathology requiring further action is commonly found during appendicectomy, macro- and microscopically. This study aims to assess whether the introduction of an acute surgical unit impacted the disclosure and management of patients with important incidental findings during appendicectomy.
连续入组
回顾性研究
Nil; this is a retrospective cohort study.
Nil; this is a retrospective cohort study.
N Kinnear received funding in relation to this work from the University of Adelaide, the Hospital Research Foundation and the National Health and Medical Research Council.
/
1200
/
2010-02-01
2015-07-31
/
Patients undergoing appendicectomy at our institution between 01/02/2010 and 31/01/2015.;
请登录查看Patients with incomplete data.;
请登录查看Dr Ned Kinnear
3011
Dr Ned Kinnear的其他临床试验
澳大利亚维多利亚省西部卫生的其他临床试验
最新临床资讯
-
大鹏制药临床III期成功
新药说2026-08-13
-
新一代 EGFR-TKI 首个全球 III 期成功
丁香园 Insight 数据库2026-08-13
-
体外诊断原料网2026-08-13
-
佰傲谷BioValley2026-08-13
-
久有基金2026-08-13
-
重庆宸安生物2026-08-13
-
UmabsDB2026-08-13
-
希格生科2026-08-13
-
bioSeedin柏思荟2026-08-13
-
智飞智讯2026-08-13
全球药物研发中心
全球研发数据与行业前沿情报
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 20 8
-
摩熵咨询 34 27
-
摩熵咨询 20 5
-
颁布机构:四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构:国家医保局 2026-07-31
-
颁布机构:国家药品审评中心(CDE) 2026-07-24
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 35 36
-
摩熵咨询 28 39
-
摩熵咨询 34 18
-
颁布机构:国家市场监督管理总局 2026-08-10
-
颁布机构:国家市场监督管理总局 2026-05-29
-
颁布机构:国家市场监督管理总局 2026-05-29
